AFM
MDCXW

Anson Funds Management’s Medicus Pharma Warrant MDCXW Stock Holding History

Anson Funds Management’s Portfolio MDCXW Stock Details MDCXW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$38.9K Buy
84,800
+42,400
+100% +$34.6K ﹤0.01% 132
2025
Q4 		$64.9K Hold
42,400
– – 0.01% 118
2025
Q3 		$98.2K Hold
42,400
– – 0.01% 107
2025
Q2 		$127K Hold
42,400
– – 0.02% 100
2025
Q1 		$158K Hold
42,400
– – 0.03% 110
2024
Q4 		$103K Buy
+42,400
New +$27.2K 0.01% 139

Other funds holding MDCXW

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's MDCXW Position: Q1 2026 in Review

Anson Funds Management increased its Medicus Pharma Warrant (MDCXW) stake by 100% in Q1 2026, buying an estimated $34.6K and bringing the position to 84,800 shares worth $38.9K. The position accounts for ﹤0.01% of the portfolio, ranked #132.

Anson Funds Management first reported a position in MDCXW in Q4 2024 and has held it in 6 quarters since. The position peaked at $158K in Q1 2025. 6 funds tracked by Wall St. Rank hold MDCXW as of Q1 2026.

  • Anson Funds Management held 84,800 shares of Medicus Pharma Warrant worth $38.9K as of Q1 2026.
  • Anson Funds Management bought 42,400 Medicus Pharma Warrant shares in Q1 2026, an estimated $34.6K.
  • Medicus Pharma Warrant made up ﹤0.01% of Anson Funds Management's portfolio in Q1 2026, its #132 holding.
  • Anson Funds Management first reported a position in Medicus Pharma Warrant in Q4 2024 and has held it in 6 quarters since.
  • Anson Funds Management's Medicus Pharma Warrant position peaked at $158K in Q1 2025.
  • 6 funds tracked by Wall St. Rank held Medicus Pharma Warrant as of Q1 2026.

Based on Anson Funds Management's 13F filing for Q1 2026, filed 14 May 2026.